- New frontiers in cancer therapy: the 11th International Meeting of the Asian Clinical Oncology Society (ACOS)
-
Chou HH
- KMID: 2130096
- J Gynecol Oncol.
- 2014 Jul;25(3):172-173.
- doi: 10.3802/jgo.2014.25.3.172
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- BRCA1/2 mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling
-
Chao A, Lin YH, Yang LY, Wu RC, Chang WY, Chang PY, Chang SC, Lin CY, Huang HJ, Lin CT, Chou HH, Huang KG, Kuo WL, Chang TC, Lai CH
- KMID: 2500476
- J Gynecol Oncol.
- 2020 Apr;31(3):e24.
- doi: 10.3802/jgo.2020.31.e24
Objective: The characteristics of patients with metachronous breast and ovarian malignancies and the pathogenic role of BRCA1/2 mutations remain poorly understood. We investigated these issues through a review of hospital... -
- CITED
-
- Close
- SHARE
-
- Close
- Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group
-
Lai CH, Vallikad E, Lin H, Yang LY, Jung SM, Liu HE, Ou YC, Chou HH, Lin CT, Huang HJ, Huang KG, Qiu J, Hung YC, Wu TI, Chang WY, Tan KT, Lin CY, Chao A, Chang CJ
- KMID: 2500404
- J Gynecol Oncol.
- 2020 Jan;31(1):e5.
- doi: 10.3802/jgo.2020.31.e5
Objectives: An Asian Gynecologic Oncology Group phase III randomized trial was conducted to determine whether maintenance chemotherapy could improve progression-free survival (PFS) in stages III/IV ovarian cancer. Methods: Between 2007 and... -
- CITED
-
- Close
- SHARE
-
- Close
